ICOS (INSIGHT-11)

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-165

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Pending
  • Research Location

    United Kingdom
  • Lead Research Institution

    MRC Clinical Trials Unit at UCL
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    N/A

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

ICOS (An International Observational Study of Outpatients with SARS-CoV-2 Infection) aims to assess the influence of demographics, source(s) of infection, co-morbid conditions, immunosuppression, and other clinical risk factors, for the global cohort and by geographic region. It opened to enrollment in June 2020.